XML 71 R39.htm IDEA: XBRL DOCUMENT v3.19.3
Financial Instruments - Schedule of Cash, Cash Equivalents and Available-for-Sale Securities by Significant Investment Category (Detail) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Sep. 30, 2018
Dec. 31, 2017
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost $ 1,147,834 $ 1,322,661    
Gross Unrealized Gains 4,928 497    
Gross Unrealized Losses (165) (2,986)    
Aggregate Fair Value 1,152,596 1,320,172    
Cash and Cash Equivalents 423,220 493,982 [1] $ 882,184 $ 598,028
Short-term Marketable Securities 297,572 590,326 [1]    
Long-term Marketable Securities 431,804 235,864 [1]    
Level 1: | Cash        
Schedule of Available-for-sale Securities [Line Items]        
Cash 294,543 228,809    
Gross Unrealized Gains 0 0    
Gross Unrealized Losses 0 0    
Aggregate Fair Value 294,543 228,809    
Cash and Cash Equivalents 294,543 228,809    
Short-term Marketable Securities 0 0    
Long-term Marketable Securities 0 0    
Level 2:        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost 853,291 1,093,852    
Gross Unrealized Gains 4,928 497    
Gross Unrealized Losses (165) (2,986)    
Aggregate Fair Value 858,054 1,091,363    
Cash and Cash Equivalents 128,678 265,173    
Short-term Marketable Securities 297,572 590,326    
Long-term Marketable Securities 431,804 235,864    
Level 2: | Money market instruments        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost 128,678 205,736    
Gross Unrealized Gains 0 0    
Gross Unrealized Losses 0 0    
Aggregate Fair Value 128,678 205,736    
Cash and Cash Equivalents 128,678 205,736    
Short-term Marketable Securities 0 0    
Long-term Marketable Securities 0 0    
Level 2: | Corporate debt securities        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost 519,693 564,852    
Gross Unrealized Gains 3,713 214    
Gross Unrealized Losses (67) (2,288)    
Aggregate Fair Value 523,339 562,778    
Cash and Cash Equivalents 0 2,000    
Short-term Marketable Securities 206,782 376,545    
Long-term Marketable Securities 316,557 184,233    
Level 2: | Commercial paper        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost   77,702    
Gross Unrealized Gains   0    
Gross Unrealized Losses   0    
Aggregate Fair Value   77,702    
Cash and Cash Equivalents   21,964    
Short-term Marketable Securities   55,738    
Level 2: | U.S. government agency securities        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost 204,371 240,436    
Gross Unrealized Gains 1,073 144    
Gross Unrealized Losses (97) (697)    
Aggregate Fair Value 205,347 239,883    
Cash and Cash Equivalents 0 31,474    
Short-term Marketable Securities 90,790 156,967    
Long-term Marketable Securities 114,557 51,442    
Level 2: | Foreign and other        
Schedule of Available-for-sale Securities [Line Items]        
Amortized Cost 549 5,126    
Gross Unrealized Gains 142 139    
Gross Unrealized Losses (1) (1)    
Aggregate Fair Value 690 5,264    
Cash and Cash Equivalents 0 3,999    
Short-term Marketable Securities 0 1,076    
Long-term Marketable Securities $ 690 $ 189    
Minimum        
Schedule of Available-for-sale Securities [Line Items]        
Long term marketable securities maturity period 1 year 1 year    
Maximum        
Schedule of Available-for-sale Securities [Line Items]        
Long term marketable securities maturity period 5 years 5 years    
Short term marketable securities maturity period 1 year 1 year    
[1]
December 31, 2018 balances were derived from the audited Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the SEC on February 28, 2019.